GGrantIndex
← Search

Developmental Funds

$1,650,897P30FY2025CANIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

PROJECT SUMMARY Developmental Funds are a critical tool in advancing the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium’s strategic priorities. These funds are used for three primary purposes: supporting new recruits in the form of New Investigator Awards, funding innovative pilot projects, and subsidizing several key staff investigators. New Investigator Awards are used to augment the recruitment packages of newly hired Consortium scientists. These additional funds enable investigators to explore high-risk ideas or generate preliminary data that can be used for future grant applications. In the most recent five years of CCSG-funded New Investigator Award competitions (2019-2023), we have supported 27 newly recruited Consortium faculty, all of whom have research aims rooted in areas of strategic growth. Pilot Awards, on the other hand, are available to all Consortium members for the purpose of funding new projects, particularly in the areas of transdisciplinary science, cancer health disparities, and catchment area health. In the most recent five years of Pilot Award competitions (2019-2023), the Consortium funded 53 Pilot Award projects with 33 funded by the CCSG and 20 funded by philanthropic funds, many of which evolved into new research directions and collaborations that would not have been possible otherwise. Although primarily funded by the CCSG, Pilot Awards are supplemented by philanthropic gifts which typically allow an additional three to eight awards to be funded annually. Since the last competing renewal, New Investigator and Pilot funding mechanisms resulted in a combined total of 85 publications and more than $39.4M in new follow-on funding, with $28.3M resulting from CCSG funds and $11.1M from philanthropic funds. Developmental Funds also support two Special Populations Staff Investigators whose work is focused on reducing disparities in underserved populations. Their research and outreach efforts are vital to advancing the Consortium’s initiatives on community engagement and health access for all. In this application, we are requesting funds to support future New Investigator and Pilot Awards and two new Special Populations Staff Investigators.

View original record on NIH RePORTER →